About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

24 Hour IOP Lowering Efficacy of AL-3789 | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 2NCT00643669

24 Hour IOP Lowering Efficacy of AL-3789

The objective of this study was to describe the intraocular pressure-lowering efficacy of AL-3789 over a 24-hour period in patients with open-angle glaucoma compared to an untreated control. Patients ...

Lead sponsor: Alcon Research•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Alcon Research

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Diagnosis of open-angle glaucoma and treated for at least 30 days prior to Screening Visit with a topical prostaglandin analog as monotherapy.

Exclusion Criteria

•Pregnant, intend to become pregnant, breastfeeding.
•Difference in IOP greater than 3 mm Hg between eyes at Screening Visit.
•Any form of glaucoma other than open-angle glaucoma.

Related studies

RECRUITINGPhase 1

A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes

NCT06267274 · Open-angle Glaucoma, Ocular Hypertension

Active Not Recruiting

Impact of Glaucoma and Visual Field Loss on Life Space

NCT03673644 · Primary Open-angle Glaucoma

Safety and Effectiveness of the Sight Sciences VISCO™360 Versus SLT in Primary Open Angle Glaucoma

NCT02928289 · Open-Angle Glaucoma

COMPLETEDPhase 3

Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension

NCT03850782 · Open-Angle Glaucoma, Ocular Hypertension

TERMINATEDPhase 1

Safety and Tolerability of a Timolol Releasing Intraocular Implant in Subjects With Primary Open-angle Glaucoma

NCT06321562 · Primary Open-angle Glaucoma

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 29, 2012Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment25

Start dateFeb 2008

Last updatedNov 29, 2012

Condition

Open-angle Glaucoma

Locations shown

Inglewood

Inglewood, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 29, 2012Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions